Teva near to naming Vigodman as CEO
Teva near to naming Vigodman as CEO
Teva Pharmaceutical Industries is expected to name board member Erez Vigodman as CEO this month, says Bloomberg. An activist shareholder is urging investors to support the appointment, adds Bloomberg.
Vigodman, the CEO of generic agrochemicals maker Makhteshim-Agan Industries Ltd., is the board’s choice for the job, though directors haven’t voted on the appointment yet. CEO Jeremy Levin was ousted in October amid a conflict with the board.
Vigodman, 54, orchestrated a turnaround at Makhteshim-Agan in the past four years. He previously ran food company Strauss Group Ltd., where he oversaw a global expansion that included buying coffee makers in Brazil and a prepared-salad company in the U.S. Now he will get a shot at reviving Israel’s biggest company as its shares trade near a six-year low and talk builds of a possible break-up.
Source: Yahoo
Boutique executive search services with best in class global network, contacts and market mastery.
Deeply connected and engaged personal service approach, long-term investment in client community and 25 year history of strong relations with both Multi-National leaders and Private Equity partners.